HEALIUS LIMITED (HLS)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HLS - HEALIUS LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX200 | ASX300 | ALL-ORDS

Healius, formerly Primary Health Care, is an Australian provider of Pathology, Diagnostic and Day Hospital services. It has been listed since 1998.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.27

25 May
2022

0.020

OPEN

$4.26

0.47%

HIGH

$4.30

1,856,581

LOW

$4.22

TARGET
$4.817 12.8% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . RHC . SHL . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
HLS: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 8.4 59.6 xxx
DPS (cps) xxx 13.3 18.0 xxx
EPS Growth xxx N/A 100.0% xxx
DPS Growth xxx 100.0% 36.0% xxx
PE Ratio xxx N/A 7.1 xxx
Dividend Yield xxx N/A 4.3% xxx
Div Pay Ratio(%) xxx 157.7% 30.2% xxx

Dividend yield today if purchased 3 years ago: 4.29%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.13

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/03 - ex-div 10c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx8.4
DPS All xxxxxxxxxxxxxxx13.3
Sales/Revenue xxxxxxxxxxxxxxx1,900.7 M
Book Value Per Share xxxxxxxxxxxxxxx310.2
Net Operating Cash Flow xxxxxxxxxxxxxxx493.3 M
Net Profit Margin xxxxxxxxxxxxxxx3.49 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx3.50 %
Return on Invested Capital xxxxxxxxxxxxxxx2.02 %
Return on Assets xxxxxxxxxxxxxxx1.59 %
Return on Equity xxxxxxxxxxxxxxx3.50 %
Return on Total Capital xxxxxxxxxxxxxxx7.33 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx388.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

23/05/2022

3

Neutral

$4.70

10.07%

Healius's 2022 strategy day reveals the company plans to divest its Day Surgery business, the sustainable investment program is a year overdue, delaying margin benefits, and trading was pretty much in line with forecasts (despite covid and flood impacts), reports Citi.

The company also detailed its digital strategy but did not reveal the required investment to progress it.

Neutral rating retained. Target rice steady at $4.70.

FORECAST
Citi forecasts a full year FY22 dividend of 15.00 cents and EPS of 63.40 cents.
Citi forecasts a full year FY23 dividend of 16.00 cents and EPS of 22.20 cents.

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

HLS STOCK CHART